ANITA THOMAS: Open Payments
NPI 1528463742 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,637 in 370 payments from 22 companies in 2025. Trend: 2023 $4,055 · 2024 $5,001 · 2025 $5,637
Food & beverage: $5,634Education: $3
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 52 | $876 |
| Otsuka America Pharmaceutical, Inc. | 61 | $610 |
| E.R. Squibb & Sons, L.L.C. | 28 | $552 |
| Neurocrine BioSciences, Inc. | 31 | $476 |
| ABBVIE INC. | 30 | $429 |
| Lundbeck LLC | 33 | $419 |
| Janssen Pharmaceuticals, Inc | 23 | $386 |
| Vanda Pharmaceuticals Inc. | 19 | $291 |
| Alkermes, Inc. | 18 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $217 |
Products named: REXULTI, COBENFY, UZEDY, INGREZZA, VRAYLAR, AUSTEDO XR, FANAPT, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
